吉贝尔(688566)_个股概要_股票价格_最新资讯_行情走势_历史数据 - 老虎社区

688566 吉贝尔

已收盘 01-10 15:00:00

{"stockData":{"symbol":"688566","market":"SH","secType":"STK","nameCN":"吉贝尔","latestPrice":21.99,"timestamp":1736492400000,"preClose":21.98,"halted":0,"volume":1164845,"delay":0,"changeRate":0.0005,"floatShares":199000000,"shares":199000000,"eps":1.1964,"marketStatus":"已收盘","change":0.01,"latestTime":"01-10 15:00:00","open":21.96,"high":22.06,"low":21.6,"amount":25462100,"amplitude":0.0209,"askPrice":21.99,"askSize":51,"bidPrice":21.96,"bidSize":198,"shortable":0,"etf":0,"ttmEps":1.1964,"tradingStatus":0,"nextMarketStatus":{"tag":"开盘","tradingStatus":2,"beginTime":1736731800000},"marketStatusCode":5,"adr":0,"adjPreClose":21.98,"symbolType":"stock_kcb","openAndCloseTimeList":[[1736472600000,1736479800000],[1736485200000,1736492400000]],"highLimit":24.18,"lowLimit":19.78,"ibTradeSell":false,"ibTradeBuySell":true,"totalEquity":199430865,"isCdr":false,"pbRate":1.94,"roa":"--","peRate":18.38014,"roe":"8.55%","epsLYR":1.17,"committee":0.539972,"marketValue":4385000000,"turnoverRate":0.0058,"status":0,"nextConnectDate":"根据港交所公布的数据，今日已停止北向交易，下一个交易日为北京时间 2025-01-13。","afterMarket":{"amount":0,"volume":0,"close":21.99,"buyVolume":0,"sellVolume":0,"time":1736494438029,"indexStatus":"已收盘 01-10 15:30:00","preClose":21.98},"floatMarketCap":4385000000},"requestUrl":"/m/hq/s/688566","defaultTab":"news","newsList":[{"id":"2502231844","title":"吉贝尔（688566）1月10日主力资金净买入98.08万元","url":"https://stock-news.laohu8.com/highlight/detail?id=2502231844","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2502231844?lang=zh_cn&edition=full","pubTime":"2025-01-11 08:17","pubTimestamp":1736554656,"startTime":"0","endTime":"0","summary":"证券之星消息，截至2025年1月10日收盘，吉贝尔报收于21.99元，上涨0.05%，换手率0.58%，成交量1.16万手，成交额2546.21万元。近5日资金流向一览见下表：吉贝尔融资融券信息显示，融资方面，当日融资买入251.47万元，融资偿还284.11万元，融资净偿还32.65万元。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2025011100009247.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["688566","BK0239"],"gpt_icon":0},{"id":"2502016996","title":"吉贝尔收盘下跌1.12%，滚动市盈率18.37倍","url":"https://stock-news.laohu8.com/highlight/detail?id=2502016996","media":"金融界","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2502016996?lang=zh_cn&edition=full","pubTime":"2025-01-09 20:17","pubTimestamp":1736425070,"startTime":"0","endTime":"0","summary":"1月9日，吉贝尔今日收盘21.98元，下跌1.12%，滚动市盈率PE达到18.37倍。从行业市盈率排名来看，公司所处的化学制药行业市盈率平均41.31倍，行业中值25.97倍，吉贝尔排名第67位。股东方面，截至2024年9月30日，吉贝尔股东户数7018户，较上次减少414户，户均持股市值35.28万元，户均持股数量2.76万股。最新一期业绩显示，2024年三季报，公司实现营业收入6.43亿元，同比4.25%；净利润1.75亿元，同比12.57%，销售毛利率89.51%。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2025010920212895fdf1a6&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2025010920212895fdf1a6&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["688566","BK0239"],"gpt_icon":0},{"id":"2501768834","title":"吉贝尔（688566）1月7日主力资金净卖出139.00万元","url":"https://stock-news.laohu8.com/highlight/detail?id=2501768834","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2501768834?lang=zh_cn&edition=full","pubTime":"2025-01-08 08:29","pubTimestamp":1736296182,"startTime":"0","endTime":"0","summary":"证券之星消息，截至2025年1月7日收盘，吉贝尔报收于22.34元，下跌0.89%，换手率0.67%，成交量1.33万手，成交额2958.67万元。近5日资金流向一览见下表：吉贝尔融资融券信息显示，融资方面，当日融资买入451.87万元，融资偿还529.63万元，融资净偿还77.76万元。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2025010800007090.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["688566","BK0239"],"gpt_icon":0},{"id":"2501020824","title":"吉贝尔收盘下跌0.89%，滚动市盈率18.67倍","url":"https://stock-news.laohu8.com/highlight/detail?id=2501020824","media":"金融界","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2501020824?lang=zh_cn&edition=full","pubTime":"2025-01-07 20:08","pubTimestamp":1736251715,"startTime":"0","endTime":"0","summary":"1月7日，吉贝尔今日收盘22.34元，下跌0.89%，滚动市盈率PE达到18.67倍。从行业市盈率排名来看，公司所处的化学制药行业市盈率平均42.20倍，行业中值26.58倍，吉贝尔排名第67位。股东方面，截至2024年9月30日，吉贝尔股东户数7018户，较上次减少414户，户均持股市值35.28万元，户均持股数量2.76万股。江苏吉贝尔药业股份有限公司的主营业务是药物研发、生产、销售。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250107201432985df52d&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250107201432985df52d&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK0239","688566"],"gpt_icon":0},{"id":"2501250302","title":"医药生物行业研究：2025年1月第一周创新药周报","url":"https://stock-news.laohu8.com/highlight/detail?id=2501250302","media":"西南证券股份有...","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2501250302?lang=zh_cn&edition=full","pubTime":"2025-01-07 00:00","pubTimestamp":1736179200,"startTime":"0","endTime":"0","summary":"A 股和港股创新药板块及XBI 指数本周走势2025年1月第一周，陆港两地创新药板块共计21个股上涨，87个股下跌。近 6 个月 A 股创新药累计上涨 11.78%，跑赢沪深 300 指数2.18pp，生物医药累计上涨 4.58%。本周港股创新药板块下跌4.59%，跑输恒生指数 2.94pp，恒生医疗保健下跌2.77%。本周美国7 款NDA 获批上市，1款BLA 获批上市。1 月日本无创新药获批上市，本周日本无新药获批上市。本周全球重点创新药交易进展本周全球共达成10 起重点交易，披露金额的重点交易有3 起。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250107153028985db197&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250107153028985db197&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK0028","600161","600513","688428","603229","163118","600613","688520","603669","688091","BK0082","600833","600572","BK0010","603127","BK0168","000808.SH","603707","BK0046","688073","159992","688302","688566","BK0185","600488","688321","688621","688710","BK0239","688180","600568","688197","BK0188","688687","600594","688373"],"gpt_icon":0},{"id":"2501401344","title":"吉贝尔01月06日遭主力抛售314万元 环比增加2142.86%","url":"https://stock-news.laohu8.com/highlight/detail?id=2501401344","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2501401344?lang=zh_cn&edition=full","pubTime":"2025-01-06 15:20","pubTimestamp":1736148039,"startTime":"0","endTime":"0","summary":"01月06日, 吉贝尔股价涨0.71%，报收22.54元，成交金额4447万元，换手率0.99%，振幅2.55%，量比1.32。吉贝尔今日主力资金净流出314万元，上一交易日主力净流出14万元，今日环比增加2142.86%。该股近5个交易日上涨0.85%，主力资金累计净流入430万元，其中1个交易日为股价下跌时净流入；近20日主力资金累计净流出804万元，其中净流出天数为12日。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250106153511a2172de0&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250106153511a2172de0&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-2","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK0239","688566"],"gpt_icon":0},{"id":"2500195330","title":"国家医保局印发《眼科类医疗服务价格项目立项指南（试行）》","url":"https://stock-news.laohu8.com/highlight/detail?id=2500195330","media":"E公司","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2500195330?lang=zh_cn&edition=full","pubTime":"2025-01-03 18:29","pubTimestamp":1735900140,"startTime":"0","endTime":"0","summary":"e公司讯，为贯彻落实《深化医疗服务价格改革试点方案》，推进全国医疗服务价格项目规范，按照“成熟一批、发布一批”的工作思路，近日国家医保局编制印发《眼科类医疗服务价格项目立项指南（试行）》，参考2023年版医疗服务项目技术规范，将563项技术规范项目映射整合为125项。下一步，国家医保局将指导各省医保局结合实际做好对接落实，制定全省统一的价格基准，由具有价格管理权限的统筹地区对照全省价格基准，上下浮动确定实际执行的价格水平。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2025010318294395f7a554&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2025010318294395f7a554&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK0060","688177","603676","600200","BK0188","600216","600713","603367","600993","BK0028","688566","600511","600267","600351","603669","600594","688321","BK0239","600671"],"gpt_icon":0},{"id":"2500916830","title":"吉贝尔01月02日主力资金流入358万元 连续5日加仓","url":"https://stock-news.laohu8.com/highlight/detail?id=2500916830","media":"市场透视","labels":["shareholding"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2500916830?lang=zh_cn&edition=full","pubTime":"2025-01-02 15:19","pubTimestamp":1735802398,"startTime":"0","endTime":"0","summary":"01月02日, 吉贝尔股价跌0.04%，报收22.39元，成交金额3589万元，换手率0.81%，振幅2.28%，量比1.19。吉贝尔今日主力资金净流入358万元，连续5日净流入，上一交易日主力净流入168万元，今日环比增加113.10%。该股近5个交易日上涨0.49%，主力资金累计净流入1108万元，其中1个交易日为股价下跌时净流入；近20日主力资金累计净流出800万元，其中净流出天数为12日。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250102153348a212805a&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250102153348a212805a&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"shareholding","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK0239","688566"],"gpt_icon":0},{"id":"2495594517","title":"吉贝尔12月30日主力资金流入229万元 连续3日加仓","url":"https://stock-news.laohu8.com/highlight/detail?id=2495594517","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2495594517?lang=zh_cn&edition=full","pubTime":"2024-12-30 15:22","pubTimestamp":1735543364,"startTime":"0","endTime":"0","summary":"12月30日, 吉贝尔股价涨0.04%，报收22.36元，成交金额3150万元，换手率0.71%，振幅2.19%，量比0.71。吉贝尔今日主力资金净流入229万元，连续3日净流入，上一交易日主力净流入190万元，今日环比增加20.53%。近一年数据显示，该股主力连续3日净流入后，次日上涨概率为44.44%，平均涨幅为2.05%。该股近5个交易日下跌0.93%，主力资金累计净流入61万元，其中1个交易日为股价上涨时净流出；近20日主力资金累计净流出1910万元，其中净流出天数为14日。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20241230153921ab97a953&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20241230153921ab97a953&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK0239","688566"],"gpt_icon":0},{"id":"2495556769","title":"【机构调研记录】金信基金调研宇瞳光学、吉贝尔","url":"https://stock-news.laohu8.com/highlight/detail?id=2495556769","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2495556769?lang=zh_cn&edition=full","pubTime":"2024-12-30 08:01","pubTimestamp":1735516918,"startTime":"0","endTime":"0","summary":"证券之星消息，根据市场公开信息及12月27日披露的机构调研信息，金信基金近期对2家上市公司进行了调研，相关名单如下：1）宇瞳光学 个股亮点：公司产品主要应用领域为安防视频监控；公司产品应用于工业机器人、服务机器人；公司给AI眼镜提供配件。2）吉贝尔 个股亮点：公司产品益肝灵胶囊为保肝药，主要成分为水飞蓟素，具有改善肝功能、保护肝细胞膜的作用，可用于急慢性肝炎等，且副作用较小。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2024123000001459.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["BK0239","688566","BK0214","300790"],"gpt_icon":0},{"id":"2495556735","title":"【机构调研记录】财通基金调研吉贝尔、恩捷股份","url":"https://stock-news.laohu8.com/highlight/detail?id=2495556735","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2495556735?lang=zh_cn&edition=full","pubTime":"2024-12-30 08:01","pubTimestamp":1735516918,"startTime":"0","endTime":"0","summary":"证券之星消息，根据市场公开信息及12月27日披露的机构调研信息，财通基金近期对2家上市公司进行了调研，相关名单如下：1）吉贝尔 个股亮点：公司产品益肝灵胶囊为保肝药，主要成分为水飞蓟素，具有改善肝功能、保护肝细胞膜的作用，可用于急慢性肝炎等，且副作用较小。以上内容为证券之星据公开信息整理，由智能算法生成，不构成投资建议。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2024123000001460.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["LU1242518931.SGD","LU1328615791.USD","BK0220","IE00B5MMRT66.SGD","SGXZ49509284.SGD","BK0239","LU1242518857.USD","EVS.SI","688566","BK0102","002812","BK0155","LU0979878070.USD","SGXZ81163826.USD","IE00B543WZ88.USD"],"gpt_icon":0},{"id":"2495556203","title":"【机构调研记录】新华基金调研吉贝尔","url":"https://stock-news.laohu8.com/highlight/detail?id=2495556203","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2495556203?lang=zh_cn&edition=full","pubTime":"2024-12-30 08:01","pubTimestamp":1735516905,"startTime":"0","endTime":"0","summary":"证券之星消息，根据市场公开信息及12月27日披露的机构调研信息，新华基金近期对1家上市公司进行了调研，相关名单如下：1）吉贝尔 个股亮点：公司产品益肝灵胶囊为保肝药，主要成分为水飞蓟素，具有改善肝功能、保护肝细胞膜的作用，可用于急慢性肝炎等，且副作用较小。以上内容为证券之星据公开信息整理，由智能算法生成，不构成投资建议。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2024123000001436.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["688566","BK0239"],"gpt_icon":0},{"id":"2495755556","title":"【机构调研记录】招商基金调研联德股份、吉贝尔","url":"https://stock-news.laohu8.com/highlight/detail?id=2495755556","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2495755556?lang=zh_cn&edition=full","pubTime":"2024-12-30 08:01","pubTimestamp":1735516904,"startTime":"0","endTime":"0","summary":"证券之星消息，根据市场公开信息及12月27日披露的机构调研信息，招商基金近期对2家上市公司进行了调研，相关名单如下：1）联德股份 个股亮点：公司近期拓展了风电设备部件生产和销售业务2）吉贝尔 个股亮点：公司产品益肝灵胶囊为保肝药，主要成分为水飞蓟素，具有改善肝功能、保护肝细胞膜的作用，可用于急慢性肝炎等，且副作用较小。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2024123000001433.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["605060","BK0239","BK0259","688566"],"gpt_icon":0},{"id":"2495267556","title":"【机构调研记录】博远基金调研吉贝尔","url":"https://stock-news.laohu8.com/highlight/detail?id=2495267556","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2495267556?lang=zh_cn&edition=full","pubTime":"2024-12-30 08:01","pubTimestamp":1735516885,"startTime":"0","endTime":"0","summary":"证券之星消息，根据市场公开信息及12月27日披露的机构调研信息，博远基金近期对1家上市公司进行了调研，相关名单如下：1）吉贝尔 个股亮点：公司产品益肝灵胶囊为保肝药，主要成分为水飞蓟素，具有改善肝功能、保护肝细胞膜的作用，可用于急慢性肝炎等，且副作用较小。旗下最近一年表现最佳的公募基金产品为博远增强回报债券A，最新单位净值为0.91，近一年增长7.17%。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2024123000001410.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["BK0239","688566"],"gpt_icon":0},{"id":"2495556891","title":"【机构调研记录】东方基金调研吉贝尔","url":"https://stock-news.laohu8.com/highlight/detail?id=2495556891","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2495556891?lang=zh_cn&edition=full","pubTime":"2024-12-30 08:00","pubTimestamp":1735516859,"startTime":"0","endTime":"0","summary":"证券之星消息，根据市场公开信息及12月27日披露的机构调研信息，东方基金近期对1家上市公司进行了调研，相关名单如下：1）吉贝尔 个股亮点：公司产品益肝灵胶囊为保肝药，主要成分为水飞蓟素，具有改善肝功能、保护肝细胞膜的作用，可用于急慢性肝炎等，且副作用较小。以上内容为证券之星据公开信息整理，由智能算法生成，不构成投资建议。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2024123000001377.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["688566","BK0239"],"gpt_icon":0},{"id":"2495568265","title":"【私募调研记录】七曜投资调研吉贝尔","url":"https://stock-news.laohu8.com/highlight/detail?id=2495568265","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2495568265?lang=zh_cn&edition=full","pubTime":"2024-12-30 08:00","pubTimestamp":1735516858,"startTime":"0","endTime":"0","summary":"根据市场公开信息及12月27日披露的机构调研信息，知名私募七曜投资近期对1家上市公司进行了调研，相关名单如下：1）吉贝尔 个股亮点：公司产品益肝灵胶囊为保肝药，主要成分为水飞蓟素，具有改善肝功能、保护肝细胞膜的作用，可用于急慢性肝炎等，且副作用较小。以上内容为证券之星据公开信息整理，由智能算法生成，不构成投资建议。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://fund.stockstar.com/RB2024123000001375.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["688566","BK0239"],"gpt_icon":0},{"id":"2495844556","title":"【私募调研记录】相聚资本调研联德股份、吉贝尔","url":"https://stock-news.laohu8.com/highlight/detail?id=2495844556","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2495844556?lang=zh_cn&edition=full","pubTime":"2024-12-30 08:00","pubTimestamp":1735516853,"startTime":"0","endTime":"0","summary":"根据市场公开信息及12月27日披露的机构调研信息，知名私募相聚资本近期对2家上市公司进行了调研，相关名单如下：1）联德股份 个股亮点：公司近期拓展了风电设备部件生产和销售业务2）吉贝尔 个股亮点：公司产品益肝灵胶囊为保肝药，主要成分为水飞蓟素，具有改善肝功能、保护肝细胞膜的作用，可用于急慢性肝炎等，且副作用较小。","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://fund.stockstar.com/RB2024123000001365.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["605060","BK0259","BK0239","688566"],"gpt_icon":0},{"id":"2495455682","title":"【私募调研记录】健顺投资调研吉贝尔","url":"https://stock-news.laohu8.com/highlight/detail?id=2495455682","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2495455682?lang=zh_cn&edition=full","pubTime":"2024-12-30 08:00","pubTimestamp":1735516844,"startTime":"0","endTime":"0","summary":"根据市场公开信息及12月27日披露的机构调研信息，知名私募健顺投资近期对1家上市公司进行了调研，相关名单如下：1）吉贝尔 个股亮点：公司产品益肝灵胶囊为保肝药，主要成分为水飞蓟素，具有改善肝功能、保护肝细胞膜的作用，可用于急慢性肝炎等，且副作用较小。以上内容为证券之星据公开信息整理，由智能算法生成，不构成投资建议。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://fund.stockstar.com/RB2024123000001351.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["BK0239","688566"],"gpt_icon":0},{"id":"2494870830","title":"吉贝尔调整部分募投项目预定可使用状态时间至不晚于2025年年底","url":"https://stock-news.laohu8.com/highlight/detail?id=2494870830","media":"财中社","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2494870830?lang=zh_cn&edition=full","pubTime":"2024-12-27 17:55","pubTimestamp":1735293300,"startTime":"0","endTime":"0","summary":"财中社12月27日电吉贝尔 发布关于调整公司部分首次公开发行股票募集资金投资项目实施进度的公告。根据公告，公司决定将部分首发募投项目的预定可使用状态时间由2024年12月31日调整至不晚于2025年12月31日，涉及项目包括“利可君片、尼群洛尔片、玉屏风胶囊等生产基地（新址）建设项目”和“研发中心（新址）建设项目”。2024年前三季度，吉贝尔实现收入6.43亿元，归母净利润1.75亿元。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2024122718045395ef1f04&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2024122718045395ef1f04&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK0239","688566"],"gpt_icon":0},{"id":"2494527848","title":"吉贝尔收盘上涨0.09%，滚动市盈率18.64倍","url":"https://stock-news.laohu8.com/highlight/detail?id=2494527848","media":"金融界","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2494527848?lang=zh_cn&edition=full","pubTime":"2024-12-26 20:38","pubTimestamp":1735216690,"startTime":"0","endTime":"0","summary":"12月26日，吉贝尔今日收盘22.3元，上涨0.09%，滚动市盈率PE达到18.64倍。从行业市盈率排名来看，公司所处的化学制药行业市盈率平均44.09倍，行业中值27.57倍，吉贝尔排名第59位。消息面上，吉贝尔11月26日接待参与了本次业绩说明会的线上投资者等1家机构调研，上市公司接待人员包括董事长、总经理耿仲毅,财务总监赵锁富,董事会秘书翟建中,独立董事陈留平。江苏吉贝尔药业股份有限公司的主营业务是药物研发、生产、销售。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2024122620422995edc673&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2024122620422995edc673&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK0239","688566"],"gpt_icon":0}],"profile":{"ret":0,"listingDate":"2020-05-18","address":"江苏省镇江市润州区高新技术产业开发园区","stockEarnings":[{"period":"1week","weight":-0.0174},{"period":"1month","weight":-0.1229},{"period":"3month","weight":-0.0479},{"period":"6month","weight":-0.0124},{"period":"1year","weight":-0.233},{"period":"ytd","weight":-0.0183}],"companyName":"江苏吉贝尔药业股份有限公司","boardCode":"AI0027","perCapita":"28417股","boardName":"医药制造业","registeredCapital":"19943万元","compareEarnings":[{"period":"1week","weight":-0.0134},{"period":"1month","weight":-0.0769},{"period":"3month","weight":-0.0153},{"period":"6month","weight":0.0664},{"period":"1year","weight":0.0976},{"period":"ytd","weight":-0.0547}],"survey":"　　江苏吉贝尔药业股份有限公司的主营业务是药物研发、生产、销售。公司的主营产品包含片剂、胶囊剂和滴眼剂三种剂型。公司是国内外唯一有能力生产利可君片的企业，也是利可君片国家药品标准起草单位。","serverTime":1736593321065,"listedPrice":23.69,"stockholders":"7018人(较上一季度减少5.57%)","compareStock":{"symbol":"000001.SH","name":"上证指数"}},"APP":{"userAgent":"Mozilla/5.0 AppleWebKit/537.36 (KHTML, like Gecko; compatible; ClaudeBot/1.0; +claudebot@anthropic.com)","isDev":false,"isTTM":false,"deviceId":"web-server-community-laohu8-v3","version":"4.30.0","shortVersion":"4.30.0","platform":"web","vendor":"web","appName":"laohu8","isIOS":false,"isAndroid":false,"isTiger":false,"isTHS":false,"isWeiXin":false,"isWeiXinMini":false,"isWeiBo":false,"isQQ":false,"isBaiduSwan":false,"isBaiduBox":false,"isDingTalk":false,"isToutiao":false,"isOnePlus":false,"isHuaWei":false,"isXiaomi":false,"isXiaomiWebView":false,"isOppo":false,"isVivo":false,"isSamsung":false,"isMobile":false},"pagemeta":{"title":"吉贝尔(688566)_个股概要_股票价格_最新资讯_行情走势_历史数据","description":"美港股上老虎。老虎社区提供吉贝尔(688566)今日价格,行情走势,历史数据,股票概要及实时的新闻资讯,近期大事等重要参考决策数据。","keywords":"吉贝尔,688566,吉贝尔股票,吉贝尔股票老虎,吉贝尔股票老虎国际,吉贝尔行情,吉贝尔股票行情,吉贝尔股价,吉贝尔股市,吉贝尔股票价格,吉贝尔股票交易,吉贝尔股票购买,吉贝尔股票实时行情,购买美股,购买港股,港股开户,美股开户,美股交易,港股交易,开通美港股账户,老虎国际行情","social":{"og_title":"吉贝尔(688566)_个股概要_股票价格_最新资讯_行情走势_历史数据","og_description":"美港股上老虎。老虎社区提供吉贝尔(688566)今日价格,行情走势,历史数据,股票概要及实时的新闻资讯,近期大事等重要参考决策数据。","og_image":"https://static.tigerbbs.com/a0b84b8debbbce3b4440f7fdd5eed2e7"}}}